China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Qu... (ments said Mr. Feng LanPresident of Chin...)

HOME >> MEDICINE >> NEWS

China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008

Date:11/20/2008

ments, said Mr. Feng Lan, President of China Shenghuo. "We continue to focus our efforts on expanding our share in the vast Chinese cardiovascular and cerebrovascular market. Our flagship product, Xuesaitong Soft Capsules, continued to perform well, and our 12 Ways cosmetics products are gradually gaining national recognition. We believe that the Company's fundamentals remain strong and our products are well regarded in China."

Conference Call Information

The Company will host a conference call, to be simultaneously webcast, on Tuesday, November 25, 2008 at 10:00 a.m. Eastern Standard Time / 11:00 p.m. Beijing Time. Interested parties may participate in the conference call by dialing +1-877-407-9205 (North America) or +1-201-689-8054 (International) approximately five to ten minutes before the call start time. A live webcast of the conference call will be available on the following website: http://www.investorcalendar.com/IC/CEPage.asp?ID=137977

A replay of the conference call will be available until December 9, 2008 at 11:59 p.m. Interested parties may access the replay by dialing +1-877-660- 6853 (North America) or + 1-201-612-7415 (International) and entering account number 286 and conference ID number 304436. An archived webcast of the conference call will be available at the website listed above until February 22, 2009.

About China Shenghuo

Founded in 1995, China Shenghuo is a specialty pharmaceutical company that focuses on the research, development, manufacture and marketing of Sanchi- based medicinal and pharmaceutical, nutritional supplement and cosmetic products. Through its subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., it owns thirty SFDA (State Food and Drug Administration) approved medicines, including the flagship product Xuesaitong Soft Capsules, which h
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine news :

1. ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China
2. China Documents First Case of Tick-Borne Disease Spread
3. Drug Information Association (DIA) Opens New Office In China
4. China Healthcare Acquisition Corp Agrees to Terminate Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
5. China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009
6. China Bio-Immunity Corporation to Report Third Quarter 2008 Financial Results
7. Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC
8. Measles Initiative Supports Disease Prevention for Children in Chinas Earthquake Zone
9. China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
10. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
11. China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008

Post Your Comments:

China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Qu...(ments said Mr. Feng LanPresident of Chin...),Health